ID: ALA3350524

Max Phase: Preclinical

Molecular Formula: C18H31IN7O14P3

Molecular Weight: 789.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1ncnc2c1nc(NCCCCCCNC(=O)CI)n2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C18H31IN7O14P3/c19-7-11(27)21-5-3-1-2-4-6-22-18-25-12-15(20)23-9-24-16(12)26(18)17-14(29)13(28)10(38-17)8-37-42(33,34)40-43(35,36)39-41(30,31)32/h9-10,13-14,17,28-29H,1-8H2,(H,21,27)(H,22,25)(H,33,34)(H,35,36)(H2,20,23,24)(H2,30,31,32)/t10-,13-,14-,17-/m1/s1

Standard InChI Key:  PPOPDFOCXKHEPV-IWCJZZDYSA-N

Associated Targets(non-human)

Adenylate kinase 2 147 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Hexokinase type I 47 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Hexokinase type II 49 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Hexokinase type III 47 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 789.31Molecular Weight (Monoisotopic): 789.0187AlogP: -0.11#Rotatable Bonds: 17
Polar Surface Area: 320.26Molecular Species: ACIDHBA: 16HBD: 9
#RO5 Violations: 3HBA (Lipinski): 21HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 0.90CX Basic pKa: 4.48CX LogP: -3.72CX LogD: -8.88
Aromatic Rings: 2Heavy Atoms: 43QED Weighted: 0.04Np Likeness Score: 0.56

References

1. Hampton A, Picker D, Nealy KA, Maeda M..  (1982)  Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 4. Interactions of adenosine 5'-triphosphate derivatives with adenylate kinases from Escherichia coli and rat tissues.,  25  (4): [PMID:6279845] [10.1021/jm00346a010]
2. Hampton A, Patel AD, Chawla RR, Kappler F, Hai TT..  (1982)  Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 5. Interactions of adenosine 5'-triphosphate derivatives with rat pyruvate kinases, Escherichia coli thymidine kinase, and yeast and rat hexokinases.,  25  (4): [PMID:7040662] [10.1021/jm00346a011]

Source